Unknown NA INTERVENTIONAL 2-arm NCT03701880

Early Use of Ivabradine in Heart Failure (Ivabradine)

The Impact of Ivabradine Administration on Clinical Outcome and Biomarkers of Decompensated Heart Failure

Sponsor: Ain Shams University

Conditions Decompensated Heart Failure Heart Failure With Reduced Ejection Fraction

Updated 5 times since 2018 Last updated: Oct 9, 2018 Started: Sep 16, 2018 Primary completion: Dec 23, 2019 Completion: Dec 23, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Decompensated Heart Failure and Heart Failure With Reduced Ejection Fraction and is currently ongoing. Ain Shams University leads this study, which shows 5 recorded versions since 2018 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Nov 2020 — Jan 2021 [monthly]

Unknown Status NA

Status: Active Not Recruiting → Unknown Status
Nov 2018 — Nov 2020 [monthly]

Active Not Recruiting NA

First recorded

Sep 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ain Shams University
Sadat City University

Data source: Ain Shams University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cairo, Egypt